These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19631733)

  • 21. Exploring Chronic Drug Effects on Microengineered Human Liver Cultures Using Global Gene Expression Profiling.
    Ware BR; McVay M; Sunada WY; Khetani SR
    Toxicol Sci; 2017 Jun; 157(2):387-398. PubMed ID: 28369597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies.
    Gunness P; Mueller D; Shevchenko V; Heinzle E; Ingelman-Sundberg M; Noor F
    Toxicol Sci; 2013 May; 133(1):67-78. PubMed ID: 23377618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT.
    Sakaguchi H; Ashikaga T; Miyazawa M; Yoshida Y; Ito Y; Yoneyama K; Hirota M; Itagaki H; Toyoda H; Suzuki H
    Toxicol In Vitro; 2006 Aug; 20(5):774-84. PubMed ID: 16337770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of new troglitazone derivatives: anti-proliferative activity in breast cancer cell lines and preliminary toxicological study.
    Salamone S; Colin C; Grillier-Vuissoz I; Kuntz S; Mazerbourg S; Flament S; Martin H; Richert L; Chapleur Y; Boisbrun M
    Eur J Med Chem; 2012 May; 51():206-15. PubMed ID: 22409968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury.
    Hadi M; Chen Y; Starokozhko V; Merema MT; Groothuis GM
    Chem Res Toxicol; 2012 Sep; 25(9):1938-47. PubMed ID: 22870868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species-specific toxicity of troglitazone on rats and human by gel entrapped hepatocytes.
    Shen C; Meng Q; Zhang G
    Toxicol Appl Pharmacol; 2012 Jan; 258(1):19-25. PubMed ID: 22085495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocarcinogenic susceptibility of rasH2 mice to troglitazone in a two-stage hepatocarcinogenesis model.
    Jin M; Saekusa Y; Dewa Y; Nishimura J; Matsumoto S; Shibutani M; Hasumi K; Mitsumori K
    Arch Toxicol; 2009 Feb; 83(2):173-81. PubMed ID: 18597072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An integrated approach to improved toxicity prediction for the safety assessment during preclinical drug development using Hep G2 cells.
    Noor F; Niklas J; Müller-Vieira U; Heinzle E
    Toxicol Appl Pharmacol; 2009 Jun; 237(2):221-31. PubMed ID: 19332084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Particles from wood smoke and traffic induce differential pro-inflammatory response patterns in co-cultures.
    Kocbach A; Herseth JI; Låg M; Refsnes M; Schwarze PE
    Toxicol Appl Pharmacol; 2008 Oct; 232(2):317-26. PubMed ID: 18674554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel in vitro system, the integrated discrete multiple organ cell culture (IdMOC) system, for the evaluation of human drug toxicity: comparative cytotoxicity of tamoxifen towards normal human cells from five major organs and MCF-7 adenocarcinoma breast cancer cells.
    Li AP; Bode C; Sakai Y
    Chem Biol Interact; 2004 Nov; 150(1):129-36. PubMed ID: 15522266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of biocompatibility and cytotoxicity using keratinocyte and fibroblast cultures.
    Wiegand C; Hipler UC
    Skin Pharmacol Physiol; 2009; 22(2):74-82. PubMed ID: 19188755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of troglitazone derivatives as potent anti-proliferative agents: towards more active and less toxic compounds.
    Bordessa A; Colin-Cassin C; Grillier-Vuissoz I; Kuntz S; Mazerbourg S; Husson G; Vo M; Flament S; Martin H; Chapleur Y; Boisbrun M
    Eur J Med Chem; 2014 Aug; 83():129-40. PubMed ID: 24953030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing the mechanism of thiazolidinedione-induced hepatotoxicity: An in vitro model in mitochondria.
    Hu D; Wu CQ; Li ZJ; Liu Y; Fan X; Wang QJ; Ding RG
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):134-41. PubMed ID: 25727309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. THP-1 monocytes but not macrophages as a potential alternative for CD34+ dendritic cells to identify chemical skin sensitizers.
    Lambrechts N; Verstraelen S; Lodewyckx H; Felicio A; Hooyberghs J; Witters H; Van Tendeloo V; Van Cauwenberge P; Nelissen I; Van Den Heuvel R; Schoeters G
    Toxicol Appl Pharmacol; 2009 Apr; 236(2):221-30. PubMed ID: 19371601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maturation of the extracellular matrix and cell adhesion molecules in layered co-cultures of HepG2 and endothelial cells.
    Ohno M; Motojima K; Okano T; Taniguchi A
    J Biochem; 2009 May; 145(5):591-7. PubMed ID: 19174545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of IL-1 beta and COX2 in silica-induced IL-6 release and loss of pneumocytes in co-cultures.
    Herseth JI; Refsnes M; Låg M; Schwarze PE
    Toxicol In Vitro; 2009 Oct; 23(7):1342-53. PubMed ID: 19580863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of an in vitro assay for the investigation of metabolism-induced drug hepatotoxicity.
    Otto M; Hansen SH; Dalgaard L; Dubois J; Badolo L
    Cell Biol Toxicol; 2008 Jan; 24(1):87-99. PubMed ID: 17549590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo.
    Kumar AP; Quake AL; Chang MK; Zhou T; Lim KS; Singh R; Hewitt RE; Salto-Tellez M; Pervaiz S; Clément MV
    Cancer Res; 2009 Nov; 69(22):8636-44. PubMed ID: 19887620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation of a novel quinone epoxide metabolite of troglitazone with cytotoxicity to HepG2 cells.
    Yamamoto Y; Yamazaki H; Ikeda T; Watanabe T; Iwabuchi H; Nakajima M; Yokoi T
    Drug Metab Dispos; 2002 Feb; 30(2):155-60. PubMed ID: 11792684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an optimized cytotoxicity assay system for CYP3A4-mediated metabolic activation via modified piggyBac transposition.
    Huang L; Zou S; Deng J; Dai T; Jiang J; Jia Y; Dai R; Xie S
    Toxicol In Vitro; 2016 Apr; 32():132-7. PubMed ID: 26706816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.